Immunos Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Total raised
€91M
€90,849,737
Funding rounds
3
Investors
14
distinct backers
Active since
2019-09
latest 2024-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood47
base rate 51% for Series C
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 12y since founding
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-18 | Series C | €9.9M | BioMed Partners,Double Point Ventures,Existing investors,Gimv,Mission BioCapital,Pfizer Ventures | View deal → |
| 2022-06-07 | Series B | €68M | BioMed Partners,Fiscus Financial,Gimv,GL Capital,Lightspeed Venture Partners,Mission BioCapital+4 more | View deal → |
| 2019-10-01 | Series A | €13M | BioMedPartners,Pfizer Venture Investments | View deal → |
Investors
14Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy